tiprankstipranks
Trending News
More News >
Renascience Inc. (JP:4889)
:4889
Japanese Market

Renascience Inc. (4889) Financial Statements

Compare
0 Followers

Renascience Inc. Financial Overview

Renascience Inc.'s market cap is currently ¥20.27B. The company's EPS TTM is ¥-6.68; its P/E ratio is 561.01; Renascience Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 132.69M¥ 194.16M¥ 100.55M¥ 139.33M¥ 209.80M
Gross Profit¥ 128.95M¥ 165.64M¥ 100.30M¥ 77.60M¥ 179.82M
Operating Income¥ -178.83M¥ -252.34M¥ -333.87M¥ -210.84M¥ -86.13M
EBITDA¥ 143.82M¥ -250.50M¥ -332.49M¥ -244.65M¥ -89.39M
Net Income¥ 113.43M¥ -258.33M¥ -335.80M¥ -254.29M¥ -100.05M
Balance Sheet
Cash & Short-Term Investments¥ 1.80B¥ 2.03B¥ 2.21B¥ 2.39B¥ 1.03B
Total Assets¥ 1.87B¥ 2.09B¥ 2.27B¥ 2.44B¥ 1.07B
Total Debt¥ 0.00¥ 356.10M¥ 309.60M¥ 199.23M¥ 475.65M
Net Debt¥ -1.80B¥ -1.67B¥ -1.90B¥ -2.19B¥ -549.99M
Total Liabilities¥ 151.21M¥ 482.11M¥ 409.76M¥ 237.17M¥ 505.10M
Stockholders' Equity¥ 1.72B¥ 1.61B¥ 1.87B¥ 2.20B¥ 561.53M
Cash Flow
Free Cash Flow¥ -177.14M¥ -232.10M¥ -286.87M¥ -231.66M¥ -90.27M
Operating Cash Flow¥ -176.34M¥ -230.52M¥ -284.64M¥ -230.49M¥ -89.25M
Investing Cash Flow¥ 382.15M¥ -1.57M¥ 232.00K¥ -296.00K¥ -1.72M
Financing Cash Flow¥ -52.18M¥ 46.50M¥ 110.37M¥ 1.59B¥ 135.65M
Currency in JPY

Renascience Inc. Earnings and Revenue History

Renascience Inc. Debt to Assets

Renascience Inc. Cash Flow

Renascience Inc. Forecast EPS vs Actual EPS